CN103157091A - Drug for treating empyrosis - Google Patents
Drug for treating empyrosis Download PDFInfo
- Publication number
- CN103157091A CN103157091A CN2013101112550A CN201310111255A CN103157091A CN 103157091 A CN103157091 A CN 103157091A CN 2013101112550 A CN2013101112550 A CN 2013101112550A CN 201310111255 A CN201310111255 A CN 201310111255A CN 103157091 A CN103157091 A CN 103157091A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- fructus
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a drug for treating empyrosis, and the drug is prepared from the following materials in parts by weight: 5-10 parts of radix scrophulariae, 10-20 parts of rhizoma zingiberis, 20-30 parts of dogwood, 10-20 pats of platycodon grandiflorum, 15-25 parts of radix angelicae, 5-15 parts of inula flower, 10-30 parts of cowherb seed, 1-15 parts of herba aristolochiae, 10-20 parts of radices sileris, 15-30 parts of ephedra, 20-30 parts of radix rehmanniae preparata, 1-20 parts of morinda officinalis, 1-20 parts of celandine, 10-25 parts of lalang grass rhizome, 10-30 parts of cocklebur fruit, 1-20 parts of emblic leafflower fruit, 15-20 parts of kamuning, 10-20 parts of kaladana,15-20 parts of herba inulae, 15-30 parts of glabrous sarcandra herb, 10-20 parts of puffball, 10-25 parts of folium sennae, 5-15 parts of aleppo avens, 1-20 parts of uniflower swisscentaury root, 15-25 parts of rhododendron dauricum, 15-25 parts of radix semiaquilegiae, 10-20 parts of verbena, 15-25 parts of cortex mori radicis, 20-30 parts of lindley eupatorium, 1-20 parts of teasel root and 10-25 parts of tabasheer. All the components of the drug for treating empyrosis in the invention are natural materials, so the drug is good in safety, clear in curative effect and suitable for large-scale promotion clinically.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicament for the treatment of burn and scald.
Background technology
Burn and scald is common injury, and the lighter cures soon, and the severe one muscle damage is hindered to skeleton, is one of obstinate wound, is also that medical circle is paid attention to problem.This disease is that body directly contacts high temp objects or is subject to the variation that strong heat radiation occurs.Clinical experience proves, burn and scald reaches 1/3rd of total body surface area and can be in peril of one's life when above.Therefore, in the urgent need to seeking more efficiently medicine.
Summary of the invention
The purpose of this invention is to provide a kind of medicament for the treatment of burn and scald.
in order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of burn and scald, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Ephedrae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Lasiosphaera Seu Calvatia 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Radix Semiaquilegiae 15-25 part, Herba Verbenae 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Radix Dipsaci 1-20 part and Concretio Silicea Bambusae 10-25 part.
preferably, the medicament for the treatment of burn and scald of the present invention is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts of Herba Aristolochiaes, 17 parts of Radix Saposhnikoviaes, 24 parts, Herba Ephedrae, 27 parts of Fructus Terminaliae Billericaees, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Lasiosphaera Seu Calvatia, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Radix Semiaquilegiaes, 14 parts of Herba Verbenae, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Radix Dipsacis and Concretio Silicea Bambusaes.
More preferably, described medicament can be tablet, dispersible tablet, capsule or decoction.
Whole compositions of the medicament for the treatment of burn and scald of the present invention are all natural materials, and safety is better, and curative effect is clear and definite, are suitable for large-scale promotion clinically.
The specific embodiment
Further illustrate the present invention below by embodiment.It should be understood that embodiments of the invention are for explanation the present invention rather than limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Except as otherwise noted, otherwise the percent in the present invention is percetage by weight.
Embodiment decoction of the present invention
take Radix Scrophulariae 7 grams, Rhizoma Zingiberis 13 grams, Fructus Corni 22 grams, Radix Platycodonis 15 grams, the Radix Angelicae Dahuricae 21 grams, Flos Inulae 13 grams, Semen Vaccariae 28 grams, Herba Aristolochiae 11 grams, Radix Saposhnikoviae 17 grams, Herba Ephedrae 24 grams, Fructus Terminaliae Billericae 27 grams, Radix Morindae Officinalis 18 grams, Herba Chelidonii 17 grams, Rhizoma Imperatae 23 grams, Fructus Xanthii 21 grams, Fructus Phyllanthi 16 grams, Folium Et Cacumen Murrayae 16 grams, Semen Pharbitidis 17 grams, Herba Inulae 19 grams, Herba Sarcandrae 15 grams, Lasiosphaera Seu Calvatia 14 grams, Folium Sennae 21 grams, Radix seu Herba Gei aleppici 11 grams, Radix Rhapontici 13 grams, Folium Rhododendri Daurici 23 grams, Radix Semiaquilegiae 24 grams, Herba Verbenae 14 grams, Cortex Mori 25 grams, Herba Eupatorii Lindleyani 26 grams, Radix Dipsaci 16 grams and Concretio Silicea Bambusae 24 grams, add 2138 milliliters of entry, in being housed, heated 3 hours under 65 ℃ by the flask of condensing tube, filter.Filtrate is concentrated into 740 milliliters, namely gets decoction of the present invention.
Experimental example
Diagnostic criteria:
The damage of I degree burn and scald is the lightest.Burn and scald skin rubefaction, pain, obviously touch a tender spot, have and ooze out or edema.During light pressure injury, the part bleaches, but there is no blister.
The damage of II degree burn and scald is darker.Skin blister.The blister bottom takes on a red color or white, has been full of liquid limpid, thickness.Touch a tender spot responsive, bleach during compressing.
Choose patient's 60 examples that meet above-mentioned standard, male's 30 examples wherein, women's 30 examples, minimal ages 5 years old, maximum 48 years old age, I degree burn and scald 42 people wherein, II degree burn and scald 18 people.
Use the decoction for preparing in embodiment to treat, every day 3 times, each oral 100 milliliters.Treating 7 days is 1 course for the treatment of.
Curative effect judging standard
1, analgesic effect: pain obviously alleviates and is that produce effects, pain relief are effectively, and pain has no and alleviates as invalid.2, antiinflammatory effect: inflammation not occurring is produce effects, and it is invalid inflammation occurring; 3, detumescence effect: disappearing after medication is that produce effects, redness get better for effectively, and redness has no subdues as invalid; 4, convergence, the removing the necrotic tissue granulation promoting effect of going to itch: be produce effects without cicatrix, slight cicatrix arranged for effectively, cicatrix is evident as invalid.All indexs are that produce effects person is judged to be recovery from illness: two or two above index produce effects, and all the other index responders are produce effects; Two or two above index nonresponders are invalid, and all the other are effective.
Through treatment, find that all patients all meets the standard of recovery from illness.
Claims (3)
1. medicament for the treatment of burn and scald, it is characterized in that, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Ephedrae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Lasiosphaera Seu Calvatia 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Radix Semiaquilegiae 15-25 part, Herba Verbenae 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Radix Dipsaci 1-20 part and Concretio Silicea Bambusae 10-25 part.
2. the medicament for the treatment of burn and scald according to claim 1, it is characterized in that, it is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts of Herba Aristolochiaes, 17 parts of Radix Saposhnikoviaes, 24 parts, Herba Ephedrae, 27 parts of Fructus Terminaliae Billericaees, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Lasiosphaera Seu Calvatia, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Radix Semiaquilegiaes, 14 parts of Herba Verbenae, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Radix Dipsacis and Concretio Silicea Bambusaes.
3. the medicament for the treatment of burn and scald according to claim 1, is characterized in that, described medicament can be tablet, dispersible tablet, capsule or decoction.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013101112550A CN103157091A (en) | 2013-03-22 | 2013-03-22 | Drug for treating empyrosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013101112550A CN103157091A (en) | 2013-03-22 | 2013-03-22 | Drug for treating empyrosis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103157091A true CN103157091A (en) | 2013-06-19 |
Family
ID=48580956
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2013101112550A Pending CN103157091A (en) | 2013-03-22 | 2013-03-22 | Drug for treating empyrosis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103157091A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103301364A (en) * | 2013-07-05 | 2013-09-18 | 李华 | Pharmaceutical composition for treating post-stroke shoulder-hand syndrome |
CN104840696A (en) * | 2015-05-18 | 2015-08-19 | 中国人民解放军第四军医大学 | Traditional Chinese medicine combination for treating qi and blood deficiency type burn |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102526494A (en) * | 2012-03-23 | 2012-07-04 | 徐玉文 | Ointment for treating burning |
CN103157087A (en) * | 2013-03-22 | 2013-06-19 | 张国 | Drug for treating femoral head necrosis |
-
2013
- 2013-03-22 CN CN2013101112550A patent/CN103157091A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102526494A (en) * | 2012-03-23 | 2012-07-04 | 徐玉文 | Ointment for treating burning |
CN103157087A (en) * | 2013-03-22 | 2013-06-19 | 张国 | Drug for treating femoral head necrosis |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103301364A (en) * | 2013-07-05 | 2013-09-18 | 李华 | Pharmaceutical composition for treating post-stroke shoulder-hand syndrome |
CN103301364B (en) * | 2013-07-05 | 2014-06-18 | 于志强 | Pharmaceutical composition for treating post-stroke shoulder-hand syndrome |
CN104840696A (en) * | 2015-05-18 | 2015-08-19 | 中国人民解放军第四军医大学 | Traditional Chinese medicine combination for treating qi and blood deficiency type burn |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101167847B (en) | Traditional Chinese medicinal white spirit preparation for effectively treating skin disease | |
CN100358571C (en) | Hot compress plaster for treating mastosis and its preparing method | |
CN103191347A (en) | Traditional Chinese medicine composition for treating gynecological inflammation | |
CN103157091A (en) | Drug for treating empyrosis | |
CN101953952B (en) | Powder for treating empyrosis | |
CN102940693A (en) | Medicine composition for treating diabetic foot | |
CN103120789B (en) | Traditional Chinese medicine composition for treating migraine | |
CN103142958A (en) | Medicament for treating perniosis | |
CN103055051B (en) | Liquid for treating burn and scald | |
CN103181963A (en) | Externally applied traditional Chinese medicinal composition for treating lumbar disc herniation | |
CN103272192B (en) | Medicament for treating perianal abscess | |
CN102552503B (en) | Traditional Chinese medicine powder used for treating cervical erosion | |
CN103007236B (en) | Chinese medicinal composition for treating ankylosing spondylitis | |
CN102284035A (en) | Chinese composition for treating rhinitis | |
CN102302753A (en) | Foot bath Chinese medicinal composition for treating heel pain of middle-aged and aged | |
CN101991660B (en) | Medicine composition for treating burns | |
CN1682877A (en) | Medicinal composition for treating cyst | |
CN103566044A (en) | Traditional Chinese medicinal composition for activating blood circulation to relieve pain | |
CN103463324B (en) | Medicinal composition for preventing or treating oral ulcer and application thereof | |
CN103550526B (en) | Medicine for treating burns and scalds in clinical nursing | |
CN102631568B (en) | Pills for treating cervical spondylosis | |
CN103070998B (en) | Externally-applied plaster for curing pain of rheumatic joints | |
CN103041059B (en) | Drug for curing vasogenic cerebral edema | |
CN103110926A (en) | Medicine for treating periodontitis | |
CN103263603B (en) | Medicine for treating arthralgia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130619 |